Buy Rating Affirmed for Personalis Amidst Rapid Commercialization and Strong Tempus AI Partnership
Tempus AI Analyst Ratings
Analysts Conflicted on These NA Names: Astera Labs, Inc. (ALAB) and Tempus AI, Inc. Class A (TEM)
Tempus AI Price Target Maintained With a $47.00/Share by Needham
Tempus AI Analyst Ratings
TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50
Buy Rating Justified for Tempus AI, Inc. Class A on Strong Q1 Performance and Upbeat 2024 Guidance
Stifel Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $45
Stifel Nicolaus Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)
TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50
Maintained Buy Rating for Tempus AI, Inc. Class A Amid Inconsequential Financial Adjustments
Needham Initiates Tempus AI at Buy With $47 Price Target
Buy Rating Affirmed for Tempus AI, Inc. on Strong Growth and AI-Driven Healthcare Innovation
Tempus AI Analyst Ratings